Geneva, June 22 -- International Clinical Trials Registry received information related to the study (ChiCTR2600126670) titled 'Clinical study evaluating the rate of coronary alignment and annular alignment achieved after using Peijia Medical's transcatheter aortic valve system (TaurusOne(R)/TaurusElite(R)/TaurusMax(R)) in the treatment of patients with severe aortic valve stenosis' on June 13.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: The First Affiliated Hospital of Soochow University
Condition:
Severe aortic valve stenosis
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-06-22
Target Sample Size: Trial group:50;
Countries of Recruitment:
China
To know more, vis...